Verheij TJ - Search Results

1

Clinical signs and symptoms predicting influenza infection.

Hak E, Moons KG, Verheij TJ, Hoes AW. Hak E, et al. Among authors: verheij tj. Arch Intern Med. 2001 May 28;161(10):1351-2. doi: 10.1001/archinte.161.10.1351. Arch Intern Med. 2001. PMID: 11371268 No abstract available.

2

Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool.

Bont J, Hak E, Hoes AW, Macfarlane JT, Verheij TJ. Bont J, et al. Among authors: verheij tj. Arch Intern Med. 2008 Jul 14;168(13):1465-8. doi: 10.1001/archinte.168.13.1465. Arch Intern Med. 2008. PMID: 18625928 No abstract available.

3

Pneumococcal vaccination of the elderly: do we need another trial?

Hak E, Grobbee DE, van Essen GA, Buskens E, Verheij TJ. Hak E, et al. Among authors: verheij tj. Arch Intern Med. 2000 Jun 12;160(11):1698-9. doi: 10.1001/archinte.160.11.1698-a. Arch Intern Med. 2000. PMID: 10847265 No abstract available.

4

Influenza vaccinations: who needs them and when?

Hak E, Hoes AW, Verheij TJ. Hak E, et al. Among authors: verheij tj. Drugs. 2002;62(17):2413-20. doi: 10.2165/00003495-200262170-00001. Drugs. 2002. PMID: 12421099 Review.

5

Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study.

Hak E, Buskens E, van Essen GA, de Bakker DH, Grobbee DE, Tacken MA, van Hout BA, Verheij TJ. Hak E, et al. Among authors: verheij tj. Arch Intern Med. 2005 Feb 14;165(3):274-80. doi: 10.1001/archinte.165.3.274. Arch Intern Med. 2005. PMID: 15710789

6

Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance.

Opstelten W, Hak E, Verheij TJ, van Essen GA. Opstelten W, et al. Among authors: verheij tj. Am J Med. 2001 Oct 15;111(6):474-9. doi: 10.1016/s0002-9343(01)00880-4. Am J Med. 2001. PMID: 11690574

7

Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease.

Hak E, Hoes AW, Grobbee DE, Lammers JW, van Essen GA, van Loon AM, Verheij TJ. Hak E, et al. Among authors: verheij tj. Am J Epidemiol. 2003 Apr 15;157(8):692-700. doi: 10.1093/aje/kwg027. Am J Epidemiol. 2003. PMID: 12697573 Free PMC article.

8

Do recommended high-risk adults benefit from a first influenza vaccination?

Hak E, Buskens E, Nichol KL, Verheij TJ. Hak E, et al. Among authors: verheij tj. Vaccine. 2006 Apr 5;24(15):2799-802. doi: 10.1016/j.vaccine.2006.01.008. Epub 2006 Jan 18. Vaccine. 2006. PMID: 16480796 Free article. Clinical Trial.

9

Prognostic factors for influenza-associated hospitalization and death during an epidemic.

Hak E, Verheij TJ, van Essen GA, Lafeber AB, Grobbee DE, Hoes AW. Hak E, et al. Among authors: verheij tj. Epidemiol Infect. 2001 Apr;126(2):261-8. doi: 10.1017/s0950268801005180. Epidemiol Infect. 2001. PMID: 11357897 Free PMC article.

10

Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients.

Looijmans-Van den Akker I, Verheij TJ, Buskens E, Nichol KL, Rutten GE, Hak E. Looijmans-Van den Akker I, et al. Among authors: verheij tj. Diabetes Care. 2006 Aug;29(8):1771-6. doi: 10.2337/dc05-2517. Diabetes Care. 2006. PMID: 16873778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters